Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 31% ± 12% | |
oligodendrocyte | 5 studies | 24% ± 5% | |
cardiac muscle cell | 4 studies | 16% ± 1% | |
smooth muscle cell | 4 studies | 21% ± 6% | |
ciliated cell | 3 studies | 26% ± 4% | |
hepatocyte | 3 studies | 43% ± 20% | |
glutamatergic neuron | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2159.19 | 89 / 89 | 97% | 10.16 | 872 / 901 |
lung | 97% | 657.34 | 563 / 578 | 98% | 10.45 | 1127 / 1155 |
pancreas | 99% | 893.29 | 326 / 328 | 93% | 7.75 | 166 / 178 |
liver | 100% | 1493.40 | 225 / 226 | 90% | 6.46 | 366 / 406 |
prostate | 99% | 582.96 | 243 / 245 | 90% | 8.90 | 451 / 502 |
stomach | 78% | 1285.39 | 281 / 359 | 97% | 11.57 | 276 / 286 |
breast | 80% | 454.98 | 368 / 459 | 92% | 10.41 | 1023 / 1118 |
bladder | 86% | 609.57 | 18 / 21 | 84% | 6.16 | 421 / 504 |
uterus | 80% | 365.36 | 136 / 170 | 83% | 6.90 | 379 / 459 |
intestine | 60% | 952.93 | 584 / 966 | 97% | 9.87 | 510 / 527 |
esophagus | 52% | 699.61 | 749 / 1445 | 97% | 16.39 | 178 / 183 |
ovary | 51% | 219.32 | 91 / 180 | 83% | 4.76 | 356 / 430 |
adrenal gland | 91% | 556.45 | 235 / 258 | 16% | 0.71 | 36 / 230 |
blood vessel | 100% | 2492.41 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 11.01 | 40 / 45 |
heart | 88% | 625.16 | 756 / 861 | 0% | 0 | 0 / 0 |
skin | 72% | 292.71 | 1311 / 1809 | 12% | 0.40 | 57 / 472 |
thymus | 63% | 203.09 | 413 / 653 | 14% | 0.59 | 84 / 605 |
muscle | 76% | 365.26 | 610 / 803 | 0% | 0 | 0 / 0 |
adipose | 63% | 296.42 | 758 / 1204 | 0% | 0 | 0 / 0 |
spleen | 49% | 124.56 | 117 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 2.37 | 14 / 29 |
brain | 32% | 110.55 | 850 / 2642 | 1% | 0.02 | 4 / 705 |
peripheral blood | 18% | 225.47 | 171 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.19 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030154 | Biological process | cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FRK |
Protein name | Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) |
Synonyms | RAK PTK5 |
Description | FUNCTION: Non-receptor tyrosine-protein kinase that negatively regulates cell proliferation. Positively regulates PTEN protein stability through phosphorylation of PTEN on 'Tyr-336', which in turn prevents its ubiquitination and degradation, possibly by reducing its binding to NEDD4. May function as a tumor suppressor. . |
Accessions | ENST00000606080.2 [P42685-1] P42685 |